Cargando…

Fungal β-Glucan-Based Nanotherapeutics: From Fabrication to Application

Fungal β-glucans are naturally occurring active macromolecules used in food and medicine due to their wide range of biological activities and positive health benefits. Significant research efforts have been devoted over the past decade to producing fungal β-glucan-based nanomaterials and promoting t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fan, Cheung, Peter Chi Keung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143420/ https://www.ncbi.nlm.nih.gov/pubmed/37108930 http://dx.doi.org/10.3390/jof9040475

Ejemplares similares

The effects of β-glucan on human immune and cancer cells
por: Chan, Godfrey Chi-Fung, et al.
Publicado: (2009)

Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kei, Nelson, et al.
Publicado: (2023)

Application of MOF-based nanotherapeutics in light-mediated cancer diagnosis and therapy
por: Zhao, Dan, et al.
Publicado: (2022)

Fungal β-glucan-facilitated cross-feeding activities between Bacteroides and Bifidobacterium species
por: Fernandez-Julia, Pedro, et al.
Publicado: (2023)

Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma
por: Yang, Chun, et al.
Publicado: (2021)

Antitumor Features of Vegetal Protein-Based Nanotherapeutics
por: Voci, Silvia, et al.
Publicado: (2020)

Structure of a fungal 1,3-β-glucan synthase
por: Zhao, Chao-Ran, et al.
Publicado: (2023)

Smart Nanotherapeutics and Lung Cancer
por: Doroudian, Mohammad, et al.
Publicado: (2021)

Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease
por: Finkelman, Malcolm A.
Publicado: (2020)

Revisiting the Vital Drivers and Mechanisms of β-Glucan Masking in Human Fungal Pathogen, Candida albicans
por: Hameed, Saif, et al.
Publicado: (2021)

Anti-HIV-1 nanotherapeutics: promises and challenges for the future
por: Mahajan, Supriya D, et al.
Publicado: (2012)

A Report on Fungal (1→3)-α-d-glucans: Properties, Functions and Application
por: Złotko, Katarzyna, et al.
Publicado: (2019)

Nanotherapeutics for treating coronavirus diseases
por: Gunathilake, Thennakoon M. Sampath U., et al.
Publicado: (2021)

Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation
por: Yan, Huize, et al.
Publicado: (2019)

Immunomodulating Effects of Fungal Beta-Glucans: From Traditional Use to Medicine
por: van Steenwijk, Hidde P., et al.
Publicado: (2021)

Regulation of Staphylococcus aureus Virulence and Application of Nanotherapeutics to Eradicate S. aureus Infection
por: Arunachalam, Kannappan, et al.
Publicado: (2023)

Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer
por: Kamaruzman, Nur Izyani, et al.
Publicado: (2019)

Potential nanotherapeutic strategies for perioperative stroke
por: An, Jingyi, et al.
Publicado: (2022)

Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1
por: Batbayar, Sainkhuu, et al.
Publicado: (2012)

Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence
por: Torosantucci, Antonella, et al.
Publicado: (2009)

Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
por: Leggio, Loredana, et al.
Publicado: (2020)

Recent Advances in Nanotherapeutics for Multiple Myeloma
por: Iannazzo, Daniela, et al.
Publicado: (2020)

β-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application
por: Murphy, Emma J., et al.
Publicado: (2020)

Intelligent nanotherapeutic strategies for the delivery of CRISPR system
por: Chen, Chao, et al.
Publicado: (2023)

Transglycosylation of Stevioside by a Commercial β-Glucanase with Fungal Extracted β-Glucans as Donors
por: Zerva, Anastasia, et al.
Publicado: (2023)

Nanotherapeutics with immunoregulatory functions for the treatment of bacterial infection
por: Yang, Dongliang, et al.
Publicado: (2023)

Nanotherapeutics: Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation (Adv. Sci. 15/2019)
por: Yan, Huize, et al.
Publicado: (2019)

Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
por: Hattab, Dima, et al.
Publicado: (2021)

From Cancer Therapy to Winemaking: The Molecular Structure and Applications of β-Glucans and β-1, 3-Glucanases
por: Caseiro, Catarina, et al.
Publicado: (2022)

Changes in the Fungal Marker β-D-Glucan After Antiretroviral Therapy and Association With Adiposity
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2019)

NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris
por: Cleare, Levi G., et al.
Publicado: (2020)

Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014)

Advances in personalized nanotherapeutics
por: Kaushik, Ajeet, et al.
Publicado: (2017)

Polymeric nanomaterials for nanotherapeutics
por: Vasile, Cornelia
Publicado: (2018)

Interaction of oxalate with β-glucan: Implications for the fungal extracellular matrix, and metabolite transport
por: Perez-Gonzalez, Gabriel, et al.
Publicado: (2023)

The Complexity of Fungal β-Glucan in Health and Disease: Effects on the Mononuclear Phagocyte System
por: Camilli, Giorgio, et al.
Publicado: (2018)

Overview of β-Glucans from Laminaria spp.: Immunomodulation Properties and Applications on Biologic Models
por: Bonfim-Mendonça, Patrícia de Souza, et al.
Publicado: (2017)

Development of a Method of Measuring β-D-Glucan and Its Use in Preemptive Therapy for Invasive Fungal Infections
por: Yoshida, Minoru
Publicado: (2021)

Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics
por: Kumar, Rachna M., et al.
Publicado: (2023)

Stimuli-Responsive Nanotherapeutics for Treatment and Diagnosis of Stroke
por: Choudhary, Manisha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3h91rhuo5kbgmoa1afhetmbpc5